Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory

We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on Emil Hartela Investing’s Substack by Emil. In this article, we will summarize the bulls’ thesis on RXRX. Recursion Pharmaceuticals, Inc.'s share was trading at $4.6300 as of September 25th. Best Biotech ETFs To Buy Photo by National Cancer Institute on Unsplash Recursion Pharmaceuticals (RXRX) is emerging as a pioneer at the intersection of biology, chemistry, and AI, with a mission to industrialize drug discovery through the creation ...